JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M312761200 on December 29, 2003

J. Biol. Chem., Vol. 279, Issue 11, 10237-10242, March 12, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/11/10237    most recent
M312761200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Araki, R.
Right arrow Articles by Abe, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Araki, R.
Right arrow Articles by Abe, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Restricted Expression and Photic Induction of a Novel Mouse Regulatory Factor X4 Transcript in the Suprachiasmatic Nucleus*

Ryoko Araki{ddagger}§, Hirokazu Takahashi{ddagger}§, Ryutaro Fukumura{ddagger}, Fuyan Sun{ddagger}, Nanae Umeda||, Mitsugu Sujino||, Shin-Ichi T. Inouye||, Toshiyuki Saito{ddagger}, and Masumi Abe{ddagger}**

From the {ddagger}Transcriptome Research Center, National Institute of Radiological Sciences, Anagawa 4-9-1, Inage-ku, Chiba-shi, Chiba 263-8555, Japan Society for the Promotion of Science, Kawaguchi Center Building, Honcho 4-1-8, Kawaguchi, Saitama 332-0012, and ||Department of Physics, Informatics and Biology, Yamaguchi University, Yoshida 1677-1, Yamaguchi-shi, Yamaguchi 753-8512, Japan

Received for publication, July 14, 2003 , and in revised form, November 21, 2003.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
The regulatory factor X (RFX) family of transcription factors is characterized by a unique and highly conserved 76-amino acid residue DNA-binding domain. Mammals have five RFX genes, but the physiological functions of their products are unknown, with the exception of RFX5. Here a mouse RFX4 transcript was identified that encodes a peptide of 735 amino acids, including the DNA-binding domain. Its expression was localized in the suprachiasmatic nucleus, the central pacemaker site of the circadian clock. Also, light exposure was found to induce its gene expression in a subjective night-specific manner. Polyclonal antibodies were prepared, and an 80-kDa band was detected in the suprachiasmatic nucleus by Western hybridization. A histochemical study showed a localization of the products in the nucleus. This is the first report on mouse RFX4, which contains the RFX DNA-binding motif. Our investigation may provide clues to the physiological function of RFX4.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
Regulatory factor X (RFX)1 is a DNA-binding protein that recognizes the X-box sequence in the transcription regulation region of major histocompatibility complex class II genes (1). It has the highly conserved DNA-binding domain (DBD) of 76 amino acids that shows a unique winged helix structure (2–5). RFX is conserved among yeast (6), fungi (7), nematodes (8), fruit flies (9), mice, and humans (3, 10).

In humans and mice, five RFX paralogous genes, RFX1, RFX2, RFX3, RFX4, and RFX5, have been identified (4, 11). The RFX1, RFX2, and RFX3 genes, products of which contain the DBD, the dimerization (DIM) domain, and some other evolutionary conserved sequences (A, B, and C), are similar to each other (4, 11). RFX4 lacks the A region (11) and RFX5 lacks the A, B, C, and DIM domains (4). Nearly all of the target genes and the physiological roles of mammalian RFX1– 4 are unknown (12–15).

Studies using mutants of the RFX orthologues in other organisms have suggested possible functions. Crt1 in Saccharomyces cerevisiae encodes a transcription repressor involved in DNA damage and the replication block checkpoint pathways (6). DAF-19 in Caenorhabditis elegans plays a critical role in ciliated sensory neuron development (8). dRFX in Drosophila melanogaster is also expressed in the sensory neurons during embryonic development (9, 16).

RFX4 was first isolated from human breast cancer cells as a chimeric molecule with the estrogen receptor (17). Two transcripts have been identified in humans (GenBankTM accession numbers AF332192 [GenBank] and AB044245 [GenBank] ) and one in mice (AK016791 [GenBank] ), but the mouse transcript fails to encode the RFX-specific DNA-binding domain. This suggests the presence of another RFX4 transcript in mice containing the DBD. Neither target genes nor the physiological role of RFX4 are known, but abundant expression in the testis and some expression in the brain have been shown in humans (11). In this study, a novel mouse RFX4 transcript from the brain was isolated and characterized.

Almost all organisms have an endogenous circadian time-keeper that governs most phenomena in the organism, including its behavior (18). The endogenous oscillator functions on a period of about, but not exactly, 24 h (19–21). This period is synchronized to the day/night environmental cycle by an entrainment mechanism (22). In mammals, the central oscillator resides in the hypothalamus suprachiasmatic nucleus (SCN) (23, 24). Interestingly, the mouse RFX4 transcript was localized to the SCN.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
 REFERENCES
 
Mice and Tissues—Male mice (C57BL/6 strain) purchased from Japan SLC, Inc. (Hamamatsu, Japan) were trained in light/dark (LD) cycles (12L:12D) for at least 10 days before being transferred to constant darkness (DD). On the 4th day under DD, the cortex and SCN were isolated by micropunching. For gene expression analysis in response to light exposure, the mice were exposed to light at circadian time (CT)14 and sacrificed 20 or 45 min later. For further RFX4 induction studies, mice exposed to light at CT6, -14, or -22 were sacrificed 45 min later. The light exposure intensity was 200 lux. Control mice were sacrificed at the same CT time points but without light exposure. To determine whether the gene expression was rhythmic, the animals were sacrificed at CT2, -6, -10, -14, -18, and -22. Then, the SCN and cortex tissues were perforated using a puncher with a 400-µm inner diameter. SCN tissues were obtained from the anterior section, and the cortical tissues were obtained near the most dorsal area from the next caudal section. The pineal gland and retina were prepared as described elsewhere (25).

RNA Preparation, cDNA Synthesis and Sequencing—Total RNA was prepared from the SCN, cortex, and testis with TRIzol (Invitrogen) and then treated with DNase-I (Invitrogen). First strand cDNA was synthesized with an oligo-(dT)18 primer using the SuperScript II First-Strand Synthesis System according to the manufacturer's instructions (Invitrogen). Reverse transcriptase (RT)-PCR was performed in a 25-µl reaction, which included 2.5 units of KOD DNA polymerase (TOYOBO, Osaka, Japan). The primers were F1 (5'-TCC ACT AGT TCT TTC TTT TCC CCT TTT ATC-3'), R1 (5'-TTA TTT GAG TGT GAA ACC ATC CAT ATC TTG-3'), F2 (5'-ACT TTC TGG TAA CTA CAT CGG CTG AAA AT-3'), and R2 (5'-CTA GAC CAG GGA CAG AAA TTC ACG TTC TC-3'). The PCR conditions were 96 °C for 4 min followed by 35 cycles of 98 °C for 20 s, 60 °C for 10 s, and 74 °C for 1.5 min. The RT-PCR products were cloned into the pGEM-T Easy vector (Promega, Madison, WI) and sequenced. To prevent any misreading due to nucleotide misincorporation by the DNA polymerase, RT-PCR was conducted independently three times. For DNA sequencing, three clones were picked from the PCR products obtained from all three independent amplifications. We aligned these 9 sequences, determined the sequence of mNYD-sp10 and bRfx4, and registered the sequences in DDBJ with accession numbers AB089184 [GenBank] and AB086957 [GenBank] , respectively.

Messenger RNA Quantification—The amount of mouse RFX4 mRNA was measured by real-time PCR using SYBR-Green PCR Master Mix (Applied Biosystems, Foster City, CA) with the ABI PRISM 7700 (Applied Biosystems) (26). The amount of mRNA was determined through normalization with the glyceraldehyde 3-phosphate dehydrogenase (Gapdh) mRNA signal. The primers were mouse RFX4 (forward, 5'-GGC ATA GCG GTG AAG GAG AG-3'; reverse, 5'-AAA GTC TGG CAG CAA TGT CC-3'), mPer2 (forward, 5'-GGT CGA CAT TAG ACG GTG CT-3'; reverse, 5'-CCC CCA AAT TCC GTA TTT CT-3') and GAPDH (forward, 5'-GAG GCC GGT GCT GAG TAT GTC GT-3'; reverse, 5'-GGT GGT GCA GGA TGC ATT GCT G-3'). Pre-heating was performed at 95 °C for 10 min followed by 50 cycles of 95 °C for 15 s, 60 °C for 30 s and 78 °C for 40 s. Five mice were used for the real-time PCR analysis for each sample point, and the analysis was performed twice.

In Situ Hybridization—Two mice were used for the in situ hybridization analysis at each sample point. Whole brain tissue was fixed in a 4% paraformaldehyde/phosphate-buffered saline solution for 24 h followed by immersion in a 20% sucrose/phosphate-buffered saline solution for 24 h. Then, the brains were sliced into 30-µm sections with a Cryostat (Leica, Nussloch, Germany). To prepare the probes for analysis, bRfx4-specific regions were amplified by RT-PCR and cloned into pGEM-T Easy (see Fig. 5C). After DNA sequence confirmation, this fragment was utilized as a probe. The primers employed were the following: forward, 5'-ATT ACT GAG TGT CCC CTC GC-3'; reverse, 5'-GGG TTC CTC CAG TAA CCC AC-3' (see Fig. 5C). Radiolabeled probes were synthesized using [{alpha}-33P]UTP (PerkinElmer Life Sciences) with the manufacturer's protocols for cRNA synthesis. Hybridization was performed as described by Tei et al. (27). The hybridized sections were exposed to BioMax film (Kodak, Rochester, NY). To determine the quantitative number of the transcripts, the optical densities of the SCN from six sections from the rostral to caudal ends were quantified with an Imaging Densitometer (Bio-Rad). The intensities of the six sections were summed after conversion into the relative optical densities produced by the 14C-acrylic standards (Amersham Biosciences). Data were normalized with respect to the difference between signal intensities in equal areas of the SCN and the corpus callosum.



View larger version (41K):
[in this window]
[in a new window]
  		FIG. 5.
Induction of the bRfx4 transcript observed by in situ hybridization. The arrows indicate the SCN. The results of in situ hybridization with the whole brain section at CT22 with the bRfx4 transcript probe are shown. A, in situ hybridization with the bRfx4-specific probe with rostral, central, and caudal sections. B, sum of the intensities obtained from all six sections prepared from the brain covering the entire SCN region. The bRfx4 mRNA level in the SCN before light exposure is defined as 100. C, the probe for in situ hybridization, the primers for the real-time PCR, and the locus for the synthetic peptides.

 
Preparation of Antibodies and Western Blot Analysis—To prepare polyclonal anti-RFX4 antibodies, rabbits were immunized with synthetic peptides (amino acids 41–60, NDENEEKENNRASKPHSTPA) (see Fig. 5C). Immunization and preparation of antiserum were performed by KITAYAMA LABES, Ina, Japan. We named the polyclonal antibody anti-bRFX4-2.

To verify the antibody specificity, two COS7 transfectants were made with either the mouse bRfx4 or FLAG-tagged mouse bRfx4 constructs. Full-length mouse bRfx4 cDNA was obtained by the PCR with primers forward 278 (5'-ATG CAT TGT GGG TTA CTG GAG-3') and reverse 2,485 (5'-TCA CTT AGC CCA TCC AGT G-3') using total RNA isolated from the SCN and cloned into the pME18S expression vector. For the FLAG-tagged mouse bRfx4 construct, the pCMV-Tag2 vector was used (Stratagene, La Jolla, CA). Both constructs were confirmed by sequencing.

The SCN and testis were prepared from male mice (C57BL/6), and their extracts were obtained as described previously (28). The extracts of the COS7 cells transfected with bRfx4 or FLAG-tagged bRfx4 were also prepared and used for a control. These extracts were separated by 7.5% SDS-PAGE and then transferred to an Immobilon polyvinylidene difluoride membrane (Millipore, Bedford, MA). The membranes were reacted with an anti-FLAG M2 monoclonal antibody (Sigma) or rabbit anti-RFX4 polyclonal antibodies followed by anti-mouse IgG (Dakocytomation, Glostrup, Denmark) or anti-rabbit IgG (Dakocytomation) treatment. Signal detection was performed with SuperSignal West Dura extended duration substrate reagent (Pierce), and quantitation was performed with a LightCapture (AE-6960, ATTO Corporation, Tokyo, Japan). Immunoprecipitation was performed according to the method described by Morotomi-Yano et al. (11). The lysis buffer consisted of 50 mM Tris-HCl (pH 7.9), 1% Nonidet P-40, 2.5 mM EDTA, 500 mM KCl, and a protease inhibitor mixture (Wako, Osaka, Japan).

Histochemical Staining—Histochemical staining was performed as described previously (29). The FLAG-bRfx4 construct was transfected into COS7 cells with LipofectAMINE 2000 (Invitrogen) in the chamber slide. 22 h later, staining was performed using M2 anti-FLAG monoclonal antibody (1:500, Sigma).


   RESULTS AND DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
REFERENCES
 
A Novel Form of Mouse RFX4 Transcript Is Expressed in the SCN—Recently, the full-length human RFX4 (hereafter referred to as hRFX4) cDNA was isolated, and the interaction of its product with other RFX products was demonstrated. Nonetheless, its physiological function remains unknown. Gene expression analysis of hRFX4 showed that its expression is restricted to the testis (11). In mice, the RFX4 (AK016791 [GenBank] ) transcript was identified in the testis, but it lacks the RFX-specific DBD (30).

RFX4 expression was examined in several tissues in mice, and its expression was found in the testis, brain, heart, and ovary with expression ratios of 1, 1/36, 1/100, and 1/200, respectively. We failed to detect its expression in other tissues such as kidney, spleen, thymus, liver, muscle, lung, and uterus. These results are consistent with the publicly expressed sequence tag (EST) information. In this study, we focused on the transcript expressed in the brain. Further analyses using the SCN and cortex tissues revealed significant expression in the SCN, which serves as a biorhythm center (Fig. 1).



View larger version (26K):
[in this window]
[in a new window]
  		FIG. 1.
Tissue-specific expression of mouse RFX4. Real-time PCR was performed using Mouse Rapid-ScanTM Gene Expression Panels (OriGene Technologies, Rockville, MD), and total RNA was prepared from the SCN and cortex. mRNA levels are relative to the amount of RFX4 mRNA in the brain, which is defined as 100. Primers were designed for regions 147–166 and 280–299 (GenBankTM accession number AK016791 [GenBank] , see Fig. 5C). The mean ± S.E. (n = 2) is indicated.

 
Two types of alternatively spliced products of RFX4, NYD-sp10 and hRFX4, have been isolated in humans. The hRFX4 product has the DBD motif, which is a characteristic of the RFX transcription factor family (11). NYD-sp10 lacks this domain. In mice, one transcript, AK016791 [GenBank] , has been identified, but it lacks the DBD motif (11, 30). To date, these findings suggest the existence of a second RFX4 transcript in mice, which encodes an RFX4 homologue containing the DBD motif. A BLAST search (31) for NYD-sp10, hRFX4, and AK016791 [GenBank] in the Uni-Gene collection of mouse ESTs (www.ncbi.nlm.nih.gov/Uni-Gene/Mm.Home.html) found a cluster (Mm. 32654, build 111) containing 35 3'-ESTs and 15 5'-ESTs. All of the 3'-ESTs and 10 of the 5'-ESTs were identical to the corresponding regions of the NYD-sp10 transcript. The other five 5'-ESTs were all isolated from neural tissues. None of the sequences in this cluster were homologous to hRFX4 or AK016791 [GenBank] . PCR using total RNA purified from the mouse brain with primers designed in the 5'-ESTs and 3'-ESTs that were registered in Mm. 32654 generated a 3.7-kbp fragment. Sequencing this fragment revealed that the transcript was different from the previously reported transcripts. The novel transcript, which we refer to as brain-specific RFX4 (bRfx4), encodes a peptide consisting of 735 amino acid residues containing the B, C, DIM, and DBD domains (Fig. 2). This is the first reported mouse RFX4, which contains the DBD motif. We also obtained a mouse orthologue of NYD-sp10, mNYD-sp10, using primers F2 and R1, which were designed using the NYD-sp10 5'-untranslated regions and 3'-untranslated regions from the mouse genome (Gen-BankTM accession number NW_000030) (Fig. 3, A and B, lane F2 + R1 in the testis). A search for bRfx4 in the public genome sequence data base revealed that the 5'-ESTs had been transcribed from novel exons upstream of the first exon of the mNYD-sp10 transcript (Fig. 3A).



View larger version (117K):
[in this window]
[in a new window]
  		FIG. 2.
Nucleotide sequence of the mouse RFX4 transcript expressed in the SCN and its deduced amino acid sequence. Domains DBD, B, C, and DIM are indicated. A termination codon ~200 bp upstream of the initial methionine codon is indicated by a box.

 



View larger version (25K):
[in this window]
[in a new window]
  		FIG. 3.
The mouse RFX4 novel transcript is expressed in the SCN. A, alternative transcripts of the mouse RFX4. The sizes of the amplified fragments are shown in parentheses. The arrows indicate the primers for RT-PCR, the results of which are shown in B. Asterisks indicate gaps in the published genomic DNA sequence. Closed boxes show the mouse cyclic AMP-response element sequence. The mouse and human sequences were compared. B, mouse RFX4 transcripts in the SCN and the testis. The primers are indicated in the upper part of the photograph. M indicates the 1-kbp ladder molecular weight marker.

 
Taken together, our findings suggest that bRfx4 expression is SCN-specific and that mNYD-sp10 and AK016791 [GenBank] expression is testis-specific. To confirm this, the expression of these mouse RFX4 transcripts was compared in the SCN and the testis using several primers specific for each transcript. We found that bRfx4 is expressed in the SCN, but mNYD-sp10 and AK016791 [GenBank] are only expressed in the testis (Fig. 3). In situ hybridization was also performed with testis sections using a bRfx4-specific probe (Fig. 5C) but failed to detect any signal (data not shown). As mentioned above, we also searched for a mouse hRFX4 orthologue, but we did not find any ESTs in the public data base.

Induction of the bRfx4 Transcript by Light Exposure— Though the disruption of the RFX5 gene causes immunodeficiency in mice (12, 15), the physiological roles of the other RFX genes in mammals are unknown. The abundant expression of mouse RFX4 in the SCN may indicate that bRfx4 function is related to the circadian clock, because the SCN is the central clock locus for circadian rhythm. After real-time PCR, in situ hybridization was performed using brain sections, and strong signals were found in the SCN with three different probes prepared from the bRfx4 transcript. We also found significant but weak signals in the nucleus accumbens of the cerebellar cortex (data not shown).

The circadian rhythm generated in the SCN is transferred to most of the peripheral tissues in the body. Although peripheral tissues also have their own oscillator, they are thought to be governed by the central clock in the SCN. The circadian gene-related phenotypes were examined in bRfx4 expression. One of these phenotypes is an induction of gene expression by light exposure in a subjective night-specific manner. To date, several such genes have been identified in the SCN (32–40). Another characteristic observed in some of the circadian genes is their rhythmic expression throughout an entire day (41–43).

The expression change of mouse bRfx4 was analyzed as a result of light exposure in the SCN using real-time PCR. We detected a slight and an ~2.5-fold induction at 20 and 45 min after light exposure, respectively (Fig. 4A). No induction was observed in the cortex, pineal gland, and retina (Fig. 4A). Three additional bRfx4 primer sets were utilized, and similar results were obtained (data not shown).



View larger version (25K):
[in this window]
[in a new window]
  		FIG. 4.
Induction of bRfx4 transcript expression by light in the SCN in a subjective night-specific manner. A, induction of the bRfx4 transcript by light exposure in the SCN at CT14. The amount of mouse bRfx4 transcript was measured using real-time PCR. The bRfx4 mRNA level in the SCN before light exposure is defined as 100. B, subjective night-specific induction of the bRfx4 transcript. The amount of mouse bRfx4 transcript was measured at 0 and 45 min after light exposure at CT6, -14, and -22. The amount of bRfx4 transcript in the SCN at CT14 before light exposure is defined as 100. C, no rhythmic expression of the bRfx4 transcript. Expression of bRfx4 and mPer2 in the SCN was measured at CT2, -6, -10, -14, -18, and -22. For both genes, the amount of mRNA in the SCN at CT2 is defined as 100. The mean ± S.E. (n = 2) is indicated.

 
Next, to test whether bRfx4 induction is subjective night-specific, its expression was measured in the SCN at CT6 (subjective day), CT14 (early subjective night), and CT22 (late subjective night) after light exposure. Whereas significant induction was detected at CT14 and CT22, little induction was observed at CT6 (Fig. 4B). No induction was detected in the cortex at any of the three CT points (Fig. 4B).

To determine whether the expression of the gene is rhythmic, gene expression was measured over a period of 1 day at 4-h intervals, CT2, -6, -10, -16, and -22. We did not detect any significant rhythmic expression in the SCN (Fig. 4C). mPer2 expression was also measured, and clear rhythmic expression was detected, confirming the assay reliability (Fig. 4C).

In situ hybridization was performed, and a clear induction of gene expression was detected in the SCN 45 min after light exposure at CT22 (Fig. 5, A and B). To confirm this, three different probes prepared from bRfx4 cDNA were utilized, each of which obtained similar results. Results using the bRfx4-specific probe are shown. Induction of gene expression was detected in all SCN sections: rostral, central, and caudal (Fig. 5A). The sum of the intensities from all six SCN sections covering the entire SCN region is shown in Fig. 5B.

It has been suggested that circadian clock entrainment is regulated at the gene expression level (22). Some light-inducible genes have been isolated in the SCN (32–40), and tremendous efforts have gone into clarifying the role of the products of such light-inducible genes in the entrainment mechanism, but multiple signal pathways in the mechanism make this difficult using the gene-disrupting approach (44–46). Here we report on a novel form of mouse RFX4 that is different from the known RFX4 transcript expressed in the testis. The expression of novel RFX4 is clearly localized in the SCN, and its induction occurs only during subjective night.

Several light-induced genes have been identified in the SCN, and a significant number of them have the cyclic AMP-response element sequence, which functions as a cis-controlling element for light induction, in the upstream region of their initiation codon (47, 48). Bioinformatic analysis revealed the presence of the cyclic AMP-response element sequence at –6,807 and –11,500 of the mouse RFX4 gene. Both sequences are conserved between mice and humans (Fig. 3A). This fact is consistent with the bRfx4 induction in response to light exposure. We also searched for the X-box sequence (GTNRCCNNR-GYAAC) (5, 11) in a 10-kbp region upstream of 19 mouse circadian rhythm genes: per1, per2, per3, bmal1, clock, cry1,2, dbp, dec1,2, e4bp4, rev-erb-{alpha}, tef, tim, vasopressin, prokineticin 2, c-fos, fosB, and nr4a2 to find the target gene of RFX4 and identified the X-box consensus sequence in per1 and per3 genomic regions. However, no X-box exists in human PER1 and PER3 genes, suggesting that these genes are not RFX4 targets.

To obtain evidence for the presence of gene products in the SCN, antibodies for mouse bRfx4 were generated using a synthetic peptide. On the other hand, full-length bRfx4 cDNA was cloned, and a FLAG-tagged bRfx4 gene was prepared and introduced into an expression vector. COS7 transfectants with these constructs were used for antibody verification. The anti-bRfx4 antibody detected a band at ~80 kDa, which has the same estimated molecular weight in both COS7 transfectants with bRfx4 or FLAG-bRfx4. The band detected in the FLAG-tagged bRfx4 transfectant was also detected by the anti-FLAG monoclonal antibody. Furthermore, the products immunoprecipitated by the anti-FLAG antibody were detected by the antibody to RFX4 and vice versa (data not shown). These results demonstrated an availability of antibodies and also indicated that the identified bRfx4 encodes an 80-kDa polypeptide in COS7 transfected cells. Interestingly, the band was comprised of four bands with small molecular mass differences, all of which were also detected by the anti-FLAG monoclonal antibody and polyclonal antibodies (Fig. 6A). Different phosphorylation patterns might explain the multiple bands. Using the antibodies, the SCN and testis were examined. A signal was detected at ~80 kDa in the SCN but not in the testis (Fig. 6A). In addition, we examined localization of bRFX4 using the COS7 cells, in which the FLAG-bRfx4 construct was introduced, and detected signals only in the nucleus (Fig. 6B). The results reported in this study suggested that the product encoded by the novel RFX4 transcript plays a role in the entrainment mechanism.



View larger version (49K):
[in this window]
[in a new window]
  		FIG. 6.
Presence of bRFX4 protein in the SCN and localization in the nucleus. A, Western hybridization with anti-bRFX4-2. Lane 1, FLAG-bRfx4 transfected COS7 cells; lane 2, SCN; and lane 3, testis. Signals by anti-{alpha}-tubulin antibody are shown as controls. B, histochemical staining of bRxf4 transfected cells with anti-bRFX4-2. Upper panel, FLAG-bRfx4 transfected COS7 cells; lower panel, COS7 cells.

 

   FOOTNOTES
 
Addendum—Since this manuscript was submitted, a paper has appeared (49) identifying the same transcripts in the brain. The authors accidentally obtained a mouse strain in which the bRfx-4 gene locus was disrupted by inserting a vector into a transgenic mouse. They could not find any transcripts of bRFX-4 in the brain of the transgenic mice. The –/– mice died within 1 h of birth, and the +/– mice exhibited marked hydrocephalus of the lateral and third ventricles.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the DDBJ/GenBankTM/EBI Data Bank with accession number(s) AB089184 [GenBank] and AB086957 [GenBank] . Back

§ Both authors contributed equally to this work. Back

** To whom correspondence should be addressed. Tel.: 81-43-206-3219; Fax: 81-43-251-4593; E-mail: abemasum{at}nirs.go.jp.

1 The abbreviations used are: RFX, regulatory factor X; DBD, DNA-binding domain; DIM, dimerization; SCN, suprachiasmatic nucleus; LD, light/dark; DD, constant darkness; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; CT, circadian time; EST, expressed sequence tag; RT, reverse transcriptase. Back


   ACKNOWLEDGMENTS
 
We thank K. Maruyama for pME18S. We thank K. Yokoro for encouragement and J. J. Rodrigue and B. Burke-Gaffney for editing the English manuscript. We are grateful to H. Nei, Y. Hoki, Y. Tsutsumi, Y. Miyamoto, K. Shingu, and K. Nishikawa for technical assistance.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 

  1. Reith, W., Barras, E., Satola, S., Kobr, M., Reinhart, D., Sanchez, C. H., and Mach, B. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 4200–4204[Abstract/Free Full Text]
  2. Reith, W., Herrero-Sanchez, C., Kobr, M., Silacci, P., Berte, C., Barras, E., Fey, S., and Mach, B. (1990) Genes Dev. 4, 1528–1540[Abstract/Free Full Text]
  3. Reith, W., Ucla, C., Barras, E., Gaud, A., Durand, B., Herrero-Sanchez, C., Kobr, M., and Mach, B. (1994) Mol. Cell. Biol. 14, 1230–1244[Abstract/Free Full Text]
  4. Emery, P., Durand, B., Mach, B., and Reith, W. (1996) Nucleic Acids Res. 24, 803–807[Abstract/Free Full Text]
  5. Gajiwala, K. S., Chen, H., Cornille, F., Roques, B. P., Reith, W., Mach, B., and Burley, S. K. (2000) Nature 403, 916–921[CrossRef][Medline] [Order article via Infotrieve]
  6. Wu, S. Y., and McLeod, M. (1995) Mol. Cell. Biol. 15, 1479–1488[Abstract]
  7. Schmitt, E. K., and Kuck, U. (2000) J. Biol. Chem. 275, 9348–9357[Abstract/Free Full Text]
  8. Swoboda, P., Adler, H. T., and Thomas, J. H. (2000) Mol. Cell 5, 411–421[CrossRef][Medline] [Order article via Infotrieve]
  9. Durand, B., Vandaele, C., Spencer, D., Pantalacci, S., and Couble, P. (2000) Gene 246, 285–293[CrossRef][Medline] [Order article via Infotrieve]
  10. Doyle, J., Hoffman, S., Ucla, C., Reith, W., Mach, B., and Stubbs, L. (1996) Genomics 35, 227–230[CrossRef][Medline] [Order article via Infotrieve]
  11. Morotomi-Yano, K., Yano, K., Saito, H., Sun, Z., Iwama, A., and Miki, Y. (2002) J. Biol. Chem. 277, 836–842[Abstract/Free Full Text]
  12. Reith, W., Satola, S., Sanchez, C. H., Amaldi, I., Lisowska-Grospierre, B., Griscelli, C., Hadam, M. R., and Mach, B. (1988) Cell 53, 897–906[CrossRef][Medline] [Order article via Infotrieve]
  13. Steimle, V., Durand, B., Barras, E., Zufferey, M., Hadam, M. R., Mach, B., and Reith, W. (1995) Genes Dev. 9, 1021–1032[Abstract/Free Full Text]
  14. Durand, B., Sperisen, P., Emery, P., Barras, E., Zufferey, M., Mach, B., and Reith, W. (1997) EMBO J. 16, 1045–1055[CrossRef][Medline] [Order article via Infotrieve]
  15. Masternak, K., Barras, E., Zufferey, M., Conrad, B., Corthals, G., Aebersold, R., Sanchez, J. C., Hochstrasser, D. F., Mach, B., and Reith, W. (1998) Nat. Genet. 20, 273–277[CrossRef][Medline] [Order article via Infotrieve]
  16. Vandaele, C., Coulon-Bublex, M., Couble, P., and Durand, B. (2001) Mech. Dev. 103, 159–162[CrossRef][Medline] [Order article via Infotrieve]
  17. Dotzlaw, H., Alkhalaf, M., and Murphy, L. C. (1992) Mol. Endocrinol. 6, 773–785[Abstract]
  18. Dunlap, J. C. (1999) Cell 96, 271–290[CrossRef][Medline] [Order article via Infotrieve]
  19. Ralph, M. R., and Menaker, M. (1988) Science 241, 1225–1227[Abstract/Free Full Text]
  20. Vitaterna, M. H., King, D. P., Chang, A. M., Kornhauser, J. M., Lowrey, P. L., McDonald, J. D., Dove, W. F., Pinto, L. H., Turek, F. W., and Takahashi, J. S. (1994) Science 264, 719–725[Abstract/Free Full Text]
  21. Cermakian, N., and Sassone-Corsi, P. (2002) Curr. Opin. Neurobiol. 12, 359–365[CrossRef][Medline] [Order article via Infotrieve]
  22. Florez, J. C., and Takahashi, J. S. (1995) Ann. Med. 27, 481–490[Medline] [Order article via Infotrieve]
  23. Inouye, S. T., and Kawamura, H. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 5962–5966[Abstract/Free Full Text]
  24. Klein, D. C., Moore, R. Y., and Reppert, S. M. (1991) Suprachiasmatic Nucleus: The Mind's Clock, Oxford University Press, New York
  25. Wiechmann, A. F. (2002) J. Pineal. Res. 33, 178–185[CrossRef][Medline] [Order article via Infotrieve]
  26. Karsai, A., Muller, S., Platz, S., and Hauser, M. T.(2002) BioTechniques 32, 790–792, 794–796[Medline] [Order article via Infotrieve]
  27. Tei, H., Okamura, H., Shigeyoshi, Y., Fukuhara, C., Ozawa, R., Hirose, M., and Sakaki, Y. (1997) Nature 389, 512–516[CrossRef][Medline] [Order article via Infotrieve]
  28. Zhou, S., Tannery, N. H., Yang, J., Puszkin, S., and Lafer, E. M. (1993) J. Biol. Chem. 268, 12655–12662[Abstract/Free Full Text]
  29. Baqui, M. M., Gereben, B., Harney, J. W., Larsen, P. R., and Bianco, A. C. (2000) Endocrinology 141, 4309–4312[Abstract/Free Full Text]
  30. Kawai, J., Shinagawa, A., Shibata, K., Yoshino, M., Itoh, M., Ishii, Y., Arakawa, T., Hara, A., Fukunishi, Y., Konno, H., Adachi, J., Fukuda, S., Aizawa, K., Izawa, M., Nishi, K., Kiyosawa, H., Kondo, S., Yamanaka, I., Saito, T., Okazaki, Y., Gojobori, T., Bono, H., Kasukawa, T., Saito, R., Kadota, K., Matsuda, H., Ashburner, M., Batalov, S., Casavant, T., Fleischmann, W., Gaasterland, T., Gissi, C., King, B., Kochiwa, H., Kuehl, P., Lewis, S., Matsuo, Y., Nikaido, I., Pesole, G., Quackenbush, J., Schriml, L. M., Staubli, F., Suzuki, R., Tomita, M., Wagner, L., Washio, T., Sakai, K., Okido, T., Furuno, M., Aono, H., Baldarelli, R., Barsh, G., Blake, J., Boffelli, D., Bojunga, N., Carninci, P., de Bonaldo, M. F., Brownstein, M. J., Bult, C., Fletcher, C., Fujita, M., Gariboldi, M., Gustincich, S., Hill, D., Hofmann, M., Hume, D. A., Kamiya, M., Lee, N. H., Lyons, P., Marchionni, L., Mashima, J., Mazzarelli, J., Mombaerts, P., Nordone, P., Ring, B., Ringwald, M., Rodriguez, I., Sakamoto, N., Sasaki, H., Sato, K., Schonbach, C., Seya, T., Shibata, Y., Storch, K. F., Suzuki, H., Toyo-oka, K., Wang, K. H., Weitz, C., Whittaker, C., Wilming, L., Wynshaw-Boris, A., Yoshida, K., Hasegawa, Y., Kawaji, H., Kohtsuki, S., and Hayashizaki, Y. (2001) Nature 409, 685–690[CrossRef][Medline] [Order article via Infotrieve]
  31. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215, 403–410[CrossRef][Medline] [Order article via Infotrieve]
  32. Kornhauser, J. M., Nelson, D. E., Mayo, K. E., and Takahashi, J. S. (1990) Neuron 5, 127–134[CrossRef][Medline] [Order article via Infotrieve]
  33. Rusak, B., McNaughton, L., Robertson, H. A., and Hunt, S. P. (1992) Brain Res. Mol. Brain Res. 14, 124–130[Medline] [Order article via Infotrieve]
  34. Guido, M. E., Rusak, B., and Robertson, H. A. (1996) Brain Res. 739, 132–138[CrossRef][Medline] [Order article via Infotrieve]
  35. Stehle, J. H., Pfeffer, M., Kuhn, R., and Korf, H. W. (1996) Neurosci. Lett. 217, 169–172[CrossRef][Medline] [Order article via Infotrieve]
  36. Romijn, H. J., Sluiter, A. A., Pool, C. W., Wortel, J., and Buijs, R. M. (1996) J. Comp. Neurol. 372, 1–8[CrossRef][Medline] [Order article via Infotrieve]
  37. Kornhauser, J. M., Mayo, K. E., and Takahashi, J. S. (1996) Behav. Genet. 26, 221–240[CrossRef][Medline] [Order article via Infotrieve]
  38. Shearman, L. P., Zylka, M. J., Weaver, D. R., Kolakowski, L. F., Jr., and Reppert, S. M. (1997) Neuron 19, 1261–1269[CrossRef][Medline] [Order article via Infotrieve]
  39. Wisor, J. P., and Takahashi, J. S. (1997) J. Comp. Neurol. 378, 229–238[CrossRef][Medline] [Order article via Infotrieve]
  40. Morris, M. E., Viswanathan, N., Kuhlman, S., Davis, F. C., and Weitz, C. J. (1998) Science 279, 1544–1547[Abstract/Free Full Text]
  41. Takahashi, J. S. (1991) Curr. Opin. Neurobiol. 1, 556–561[CrossRef][Medline] [Order article via Infotrieve]
  42. Panda, S., Antoch, M. P., Miller, B. H., Su, A. I., Schook, A. B., Straume, M., Schultz, P. G., Kay, S. A., Takahashi, J. S., and Hogenesch, J. B. (2002) Cell 109, 307–320[CrossRef][Medline] [Order article via Infotrieve]
  43. Ueda, H. R., Chen, W., Adachi, A., Wakamatsu, H., Hayashi, S., Takasugi, T., Nagano, M., Nakahama, K., Suzuki, Y., Sugano, S., Iino, M., Shigeyoshi, Y., and Hashimoto, S. (2002) Nature 418, 534–539[CrossRef][Medline] [Order article via Infotrieve]
  44. Honrado, G. I., Johnson, R. S., Golombek, D. A., Spiegelman, B. M., Papaioannou, V. E., and Ralph, M. R. (1996) J. Comp. Physiol. (A) 178, 563–570[Medline] [Order article via Infotrieve]
  45. Kilduff, T. S., Vugrinic, C., Lee, S. L., Milbrandt, J. D., Mikkelsen, J. D., O'Hara, B. F., and Heller, H. C. (1998) J. Biol. Rhythms 13, 347–357[Abstract]
  46. Gillette, M. U. (1997) Curr. Opin. Neurobiol. 7, 797–804[CrossRef][Medline] [Order article via Infotrieve]
  47. Ginty, D. D., Kornhauser, J. M., Thompson, M. A., Bading, H., Mayo, K. E., Takahashi, J. S., and Greenberg, M. E. (1993) Science 260, 238–241[Abstract/Free Full Text]
  48. Gau, D., Lemberger, T., von Gall, C., Kretz, O., Le Minh, N., Gass, P., Schmid, W., Schibler, U., Korf, H. W., and Schutz, G. (2002) Neuron 34, 245–253[CrossRef][Medline] [Order article via Infotrieve]
  49. Blackshear, P. J., Graves, J. P., Stumpo, D. J., Cobos, I., Rubenstein, J. L., and Zeldin, D. C. (2003) Development 130, 4539–4552[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
D. Zhang, G. J. Harry, P. J. Blackshear, and D. C. Zeldin
G-protein Pathway Suppressor 2 (GPS2) Interacts with the Regulatory Factor X4 Variant 3 (RFX4_v3) and Functions as a Transcriptional Co-activator
J. Biol. Chem., March 28, 2008; 283(13): 8580 - 8590.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y. Lubelsky, N. Reuven, and Y. Shaul
Autorepression of Rfx1 Gene Expression: Functional Conservation from Yeast to Humans in Response to DNA Replication Arrest
Mol. Cell. Biol., December 1, 2005; 25(23): 10665 - 10673.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/11/10237    most recent
M312761200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Araki, R.
Right arrow Articles by Abe, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Araki, R.
Right arrow Articles by Abe, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.